28 May 2024 | 01:10 PM
Stocks
Kilitch Drugs Standalone March 2024 Net Sales at Rs 39.14 crore
Reported Standalone quarterly numbers for Kilitch Drugs (India) are: Net Sales at Rs 39.14 crore in March 2024 down 9.58% from Rs. 43.28 crore in March 2023. Quarterly Net Profit at Rs. 3.64 crore in March 2024 down 28.98% from Rs. 5.13 crore in March 2023. EBITDA stands at Rs. 6.11 crore in March 2024 down 24.75% from Rs. 8.12 crore in March 2023.